Hypothesis 2: Among patients who continue to meet criteria for MDD after four weeks of treatment, both those randomized to .7 grams and those randomized to 1.5 grams daily of EPA supplementation will show a greater mean improvement in MADRS scores after an additional six weeks than will those assigned to placebo supplementation.